Autolus Therapeutics plc (AUTL)

NASDAQ: AUTL · Real-Time Price · USD

2.150

-0.070 (-3.15%)

At close: Aug 14, 2026, 4:00 PM EDT

2.165

+0.015 (0.68%)

After-hours: Aug 14, 2026, 7:59 PM EDT

Autolus Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	572	530	625	1,120	329	378
Market Cap Growth	16.85%	-15.31%	-44.17%	240.67%	-13.12%	-19.06%
Enterprise Value	371	487	269	1,057	233	227
Last Close Price	2.15	1.99	2.35	6.44	1.90	5.19
PS Ratio	4.87	7.03	61.80	659.69	51.70	162.43
PB Ratio	-	2.97	1.46	10.05	1.10	1.21
P/TBV Ratio	-	3.35	1.51	10.05	1.10	1.21
EV/Sales Ratio	3.16	6.47	26.63	622.48	36.69	97.51
Debt / Equity Ratio	-	1.92	0.70	2.01	0.50	0.22
Net Debt / Equity Ratio	-	0.23	-0.68	-0.14	-0.78	-0.77
Net Debt / EBITDA Ratio	0.85	-0.16	1.25	0.09	1.71	1.84
Net Debt / FCF Ratio	-	-0.13	1.27	0.10	1.89	1.91
Asset Turnover	0.19	0.11	0.02	0.00	0.01	0.01
Inventory Turnover	-	11.11	-	-	-	-
Quick Ratio	2.93	5.13	10.48	5.90	8.87	11.79
Current Ratio	4.89	5.94	10.88	6.15	9.18	12.15
Return on Equity (ROE)	-	-94.98%	-81.91%	-101.61%	-48.64%	-54.30%
Return on Assets (ROA)	-25.44%	-24.62%	-26.01%	-25.35%	-19.94%	-25.07%
Return on Capital Employed (ROCE)	-58.20%	-52.40%	-33.40%	-53.10%	-32.20%	-37.20%
Earnings Yield	-48.96%	-54.29%	-35.28%	-18.60%	-45.27%	-37.55%
FCF Yield	-50.12%	-57.14%	-36.51%	-13.98%	-37.45%	-33.48%
Buyback Yield / Dilution	-2.10%	-4.30%	-46.69%	-83.11%	-31.78%	-39.81%

SEC Filings: 10-K · 10-Q